CERT – certara, inc. (US:NASDAQ)
Stock Stats
News
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions [Yahoo! Finance]
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
Certara, Inc. (NASDAQ: CERT) had its price target raised by analysts at Barclays PLC from $12.00 to $13.00. They now have an "equal weight" rating on the stock.
Certara, Inc. (NASDAQ: CERT) had its "market perform" rating re-affirmed by analysts at William Blair.
Form 4 Certara, Inc. For: Apr 01 Filed by: Aspbury Robert
Form 4 Certara, Inc. For: Apr 01 Filed by: Pedersen Leif E
Form 4 Certara, Inc. For: Apr 01 Filed by: Gallagher John E
Form 4 Certara, Inc. For: Apr 01 Filed by: Feehery William F
Form 144 Certara, Inc. Filed by: SMITH PATRICK F
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.